You are here

  • Home
  • Archive
  • Volume 3, Issue Suppl 2
  • Preliminary results from a Phase I/II study of epacadostat (incb024360) in combination with pembrolizumab in patients with selected advanced cancers

Article metrics

Article menu

Download PDFPDF

Oral Presentation
Preliminary results from a Phase I/II study of epacadostat (incb024360) in combination with pembrolizumab in patients with selected advanced cancers

 

Online download statistics by month:

Online download statistics by month: December 2019 to June 2025

AbstractFullPdf
Dec 2019040
Jan 2020030
Feb 2020041
Mar 2020040
Apr 2020081
May 2020060
Jun 20200160
Jul 2020081
Aug 2020061
Sep 20200196
Oct 2020092
Nov 20200148
Dec 20200124
Jan 2021031
Feb 2021092
Mar 2021040
Apr 20210114
May 2021097
Jun 20210100
Jul 2021071
Aug 2021052
Sep 2021090
Oct 20210192
Nov 20210141
Dec 20210150
Jan 20220112
Feb 20220153
Mar 20220121
Apr 2022091
May 2022090
Jun 2022070
Jul 2022091
Aug 20220112
Sep 20220132
Oct 2022070
Nov 20220212
Dec 20220263
Jan 20230240
Feb 20230111
Mar 20230302
Apr 2023093
May 2023022
Jun 20230111
Jul 2023078
Aug 2023042
Sep 20230384
Oct 202301034
Nov 202303313
Dec 20230131
Jan 20240144
Feb 20240185
Mar 202401210
Apr 20240135
May 20240218
Jun 20240122
Jul 20240194
Aug 20240176
Sep 20240217
Oct 20240173
Nov 20240182
Dec 20240142
Jan 20250105
Feb 20250132
Mar 20250177
Apr 20250145
May 20250203
Jun 20250219
Total01252181